简易SOF衰弱表型与社区老年人增量医疗费用相关
本研究纳入8264名社区居住的按服务收费医保受益人,评估简易SOF衰弱表型与后续医疗费用的关联。在控制理赔数据衍生的多病共存和衰弱指标后,SOF衰弱者年均增量总费用在女性为7142美元、男性为5961美元,略低于CHS衰弱表型的增量费用(女性9422美元、男性6479美元)。SOF衰弱与住院、专业护理机构和家庭医疗 sectors 的更高支出相关。
要点
- SOF衰弱表型在控制理赔指标后仍与更高的后续总费用和分部门费用相关。
- SOF衰弱的增量费用略低于CHS衰弱表型,但评估更简便。
- SOF表型适用于空间和时间受限的临床场景,识别高费用风险老年人。
核心结论
- 在控制理赔数据衍生的多病共存和衰弱指标后,SOF衰弱表型仍与更高的后续总费用和分部门费用相关。
- SOF表型的增量费用仅略低于CHS表型,但评估更简便,适合常规临床使用。
研究设计与样本
- 前瞻性研究,利用四项老年人队列研究数据与Medicare理赔数据链接。
- 样本为8264名社区居住的按服务收费医保受益人(女性4389人,男性3875人)。
主要发现
- 年均总医疗费用(2023美元)女性为15021美元,男性为15711美元。
- 控制理赔多病共存和衰弱指标后,SOF衰弱(2或3个组分)相比健壮(0个组分)的年均增量费用女性为7142美元、男性为5961美元。
- CHS衰弱表型的增量费用女性为9422美元、男性为6479美元。
- SOF衰弱在两性中均与住院、专业护理机构和家庭医疗 sectors 的更高后续支出相关。
关键数值与推荐
- SOF衰弱表型包括三个组分:体重下降、精力差、不能不用手臂从椅子上站起五次。
- CHS衰弱表型使用五个组分操作化定义。
- 参与者按每种表型分为健壮、衰弱前期或衰弱。
临床怎么用
- 在空间和时间受限的临床环境中,可便捷地使用SOF表型评估衰弱,以识别高费用风险的老年人。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frailty defined by the Cardiovascular Health Study (CHS) phenotype is associated with higher healthcare expenditures in community-dwelling Medicare beneficiaries after accounting for claims-based cost indicators. However, frailty assessment using the CHS phenotype is often not feasible in routine clinical practice. We evaluated whether frailty identified by the simple Study of Osteoporotic Fractures (SOF) phenotype is associated with subsequent incremental costs after accounting for claims-derived cost indicators. METHODS: Prospective study utilizing data from four cohort studies of older adults linked with Medicare claims composed of 8264 community-dwelling fee-for-service beneficiaries (4389 women, 3875 men). SOF Frailty Phenotype (three components: weight loss, poor energy, and inability to rise from chair five times without using arms) and CHS Frailty Phenotype (operationalized using five components) derived from cohort data. Participants were classified as robust, prefrail, or frail using each phenotype. Multimorbidity index (CMS Hierarchical Conditions Categories score) and Kim frailty indicator (approximating the deficit accumulation index) derived from claims. Annualized total and sector-specific healthcare costs ascertained for 36 months after frailty assessment. RESULTS: Average annualized total healthcare costs (2023 US dollars) were $15,021 in women and $15,711 in men. After accounting for claims-based multimorbidity and frailty indicators, average incremental costs of SOF phenotypic frailty (two or three components) versus robust (none) were $7142 in women and $5961 in men, only modestly lower than incremental costs of CHS phenotypic frailty ($9422 in women, $6479 in men). SOF phenotypic frailty in both sexes was associated with higher subsequent expenditures in the inpatient, skilled nursing facility, and home healthcare sectors. CONCLUSIONS: As observed with CHS phenotypic frailty, SOF phenotypic frailty is associated with higher subsequent total and sector-specific expenditures after accounting for claims-derived indicators. The parsimonious SOF phenotype can be readily assessed in space-constrained and time-limited practice settings to improve identification of older adults at high risk of costly care.
引用
- Ensrud KE, Schousboe JT, Kats AM, et al. Incremental healthcare costs of the simple SOF measure of phenotypic frailty in community-dwelling older adults. J Am Geriatr Soc. 2024. PMID: 39588718. doi:10.1111/jgs.19287
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。